Add like
Add dislike
Add to saved papers

AN ALGORITHM FOR PROGNOSIS OF RECURRENT MYOCARDIAL INFARCTION IN TYPE 2 DIABETES MELLITUS PATIENTS FOLLOWING DETERMINATION OF ENDOTHELIAL DYSFUNCTION MARKERS.

The combination of cardiac pathology and metabolic disorders, namely type 2 diabetes mellitus, is one of the most frequent comorbid pathologies and the main cause of death from cardiovascular complications at an early stage of the disease. Despite the wide range of antithrombogenic measures, prevention of thrombotic complications of acute myocardial infarction remains an urgent problem of cardiology. The study involved examination of 73 patients with acute myocardial infarction with concomitant type 2 diabetes mellitus, who were distributed into clusters according to severity by the main indices of lipid and carbohydrate metabolism using hierarchical analysis. 43 patients (3 persons from Cluster 1 and 40 from Cluster 2) had complications in the form of recurrent myocardial infarction. The study implied elaboration of the system of recurrent myocardial infarction in patients with type 2 diabetes mellitus, involving a group of classifiers based on a discriminant model and a scoring system of prediction. Routine indices (insulin, cholesterol, EDV, creatinine phosphokinase) and specific markers (asymmetric dimethylarginine and type 1 plasminogen activator inhibitor) were used as predictors. The system of mathematical prediction of recurrent myocardial infarction has a high sensitivity (84.1%) and specificity (93.1%) with a total accuracy of 87.7%, which allows it to be used in modern clinical practice to prevent the occurrence of undesirable cardiovascular events.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

Managing Alcohol Withdrawal Syndrome.Annals of Emergency Medicine 2024 March 26

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app